Table 1 Patients with PV during COVID-19 period
From: Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy
HIV viremia | Number of patients | Total cohort | |||||
|---|---|---|---|---|---|---|---|
Before PV | During COVID-19 period | After PV | Period A (n = 73) | Period B (n = 26) | COVID-19 period (A + B) (n = 99) | COVID-19 period (A + B) (n = 3537) | |
Group 1 | PV | PV | PV | 25 (34%) | 11 (42%) | 36 (36.4%) | 36 (1%) |
Group 2 | NV | PV | PV | 34 (46%) | 2 (7.6%) | 36 (36.4%) | 36 (1%) |
Group 3 | NV | PV | NV | 8 (11%) | 6 (23%) | 14 (14.2%) | 14 (0.4%) |
Group 4 | NV | PV | NA | 6 (82%) | 7 (27%) | 13 (13.2%) | 13 (0.4%) |